To evaluate the anti-inflammatory effects, cells were pretreated with EVs and CDVs at concentrations of 0.1%, 0.5%, 1%, and 2% for 1 h, followed by stimulation with lipopolysaccharide (LPS, Sigma, St
Rho GTPases and their roles in cancer metabolism
[1] In the SURMOUNT-1 clinical trial, higher doses in non-diabetic adults demonstrated significant weight loss, with participants losing approximately 15-20% of body weight over 72 weeks
Additional information The EMBO Journal (2023) 42: e112351 Supplementary Information Rights and permissions This is an open access article under the terms of the Creative Commons AttributionNonCommercialNoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is noncommercial and no modifications or adaptations are made
VWD illustrates how real-world data can help uncover diagnostic delays, quantify disease burden, and better understand patient journeys
BMJ 318 , 13751381 (1999)